05.09.2019 • News

Arcinova Appoints Roger Kilburn as CEO

Arcinova has appointed Roger Kilburn as its new CEO. Source: Arcinova
Arcinova has appointed Roger Kilburn as its new CEO. Source: Arcinova

UK-based contract development and manufacturing organization (CDMO) Arcinova has appointed Roger Kilburn as its new CEO, effective immediately. The previous CEO, Ian Shott, has assumed the position of executive chairman.

Kilburn has more than 25 years of international experience in the pharmaceutical and chemical industries. He has worked in a variety of roles within general management, marketing, sales, manufacturing, projects and engineering. Prior to his most recent position as CEO of IBioIC, Kilburn worked for Johnson Matthey and ICI in business leader positions. He holds a 1st class honors degree in chemical engineering from the University of Glamorgan.

Ian Shott commented, “I am delighted that Roger is taking over this crucial role and certain that his experience leading both Macfarlan Smith in Edinburgh and JM Pharma Services in Boston, Massachusetts gives him an excellent foundation to steer Arcinova through its critical scale up phase, creating a strong and sustainable medium sized enterprise.”

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read